Citadel Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.6M Buy
141,650
+107,899
+320% +$22.1M ﹤0.01% 2083
2025
Q4
$8.64M Sell
33,751
-288,273
-90% -$75.6M ﹤0.01% 3449
2025
Q3
$83.8M Sell
322,024
-381,096
-54% -$100M 0.01% 973
2025
Q2
$172M Sell
703,120
-776
-0.1% -$193K 0.03% 470
2025
Q1
$186M Sell
703,896
-602,723
-46% -$163M 0.04% 393
2024
Q4
$332M Buy
1,306,619
+789,227
+153% +$212M 0.06% 238
2024
Q3
$164M Sell
517,392
-776,691
-60% -$276M 0.03% 440
2024
Q2
$484M Buy
1,294,083
+219,922
+20% +$74.3M 0.1% 130
2024
Q1
$372M Sell
1,074,161
-428,981
-29% -$163M 0.07% 188
2023
Q4
$688M Sell
1,503,142
-86,774
-5% -$42.8M 0.14% 72
2023
Q3
$774M Buy
1,589,916
+1,355,422
+578% +$637M 0.17% 56
2023
Q2
$105M Sell
234,494
-783,205
-77% -$394M 0.02% 589
2023
Q1
$494M Buy
1,017,699
+973,754
+2,216% +$481M 0.11% 92
2022
Q4
$22.5M Sell
43,945
-1,105,232
-96% -$581M 0.01% 1835
2022
Q3
$558M Buy
1,149,177
+40,419
+4% +$19.7M 0.13% 80
2022
Q2
$519M Buy
1,108,758
+223,219
+25% +$99.3M 0.13% 84
2022
Q1
$385M Buy
885,539
+484,723
+121% +$203M 0.08% 155
2021
Q4
$186M Sell
400,816
-78,265
-16% -$34.6M 0.04% 377
2021
Q3
$186M Sell
479,081
-160,721
-25% -$68.2M 0.04% 372
2021
Q2
$283M Buy
639,802
+89,561
+16% +$39.1M 0.06% 215
2021
Q1
$231M Buy
550,241
+293,991
+115% +$117M 0.06% 246
2020
Q4
$105M Buy
256,250
+103,542
+68% +$43M 0.03% 521
2020
Q3
$63.2M Sell
152,708
-100,404
-40% -$40.4M 0.02% 709
2020
Q2
$98.1M Buy
253,112
+99,256
+65% +$37.1M 0.04% 417
2020
Q1
$48.3M Sell
153,856
-299,371
-66% -$101M 0.02% 658
2019
Q4
$166M Buy
453,227
+121,288
+37% +$38.5M 0.07% 222
2019
Q3
$84.9M Sell
331,939
-482,491
-59% -$135M 0.04% 473
2019
Q2
$216M Buy
814,430
+532,517
+189% +$135M 0.1% 143
2019
Q1
$75M Buy
281,913
+55,497
+25% +$16M 0.04% 500
2018
Q4
$64.9M Buy
226,416
+192,171
+561% +$60.9M 0.04% 498
2018
Q3
$11.6M Sell
34,245
-19,476
-36% -$6.33M 0.01% 1941
2018
Q2
$16M Sell
53,721
-57,508
-52% -$16.8M 0.01% 1504
2018
Q1
$29.9M Sell
111,229
-301,890
-73% -$81.7M 0.02% 853
2017
Q4
$102M Buy
413,119
+336,285
+438% +$83M 0.06% 322
2017
Q3
$18.7M Sell
76,834
-88,652
-54% -$21.7M 0.01% 1105
2017
Q2
$39.8M Buy
165,486
+100,200
+153% +$22.7M 0.03% 608
2017
Q1
$13.5M Buy
+65,286
New +$13.5M 0.01% 1232
2016
Q3
Sell
-37,903
Closed -$6.58M 7430
2016
Q2
$6.82M Sell
37,903
-47,751
-56% -$8.48M 0.01% 1555
2016
Q1
$15.7M Sell
85,654
-54,882
-39% -$9.52M 0.02% 896
2015
Q4
$25.1M Sell
140,536
-55,546
-28% -$9.75M 0.03% 718
2015
Q3
$35.1M Sell
196,082
-352,570
-64% -$65.2M 0.03% 585
2015
Q2
$105M Buy
548,652
+231,178
+73% +$42.9M 0.09% 220
2015
Q1
$56.5M Sell
317,474
-235,893
-43% -$37.3M 0.05% 427
2014
Q4
$79.5M Sell
553,367
-349,263
-39% -$47.7M 0.08% 271
2014
Q3
$118M Sell
902,630
-77,546
-8% -$9.86M 0.12% 143
2014
Q2
$125M Buy
980,176
+152,850
+18% +$18.1M 0.14% 118
2014
Q1
$93.3M Buy
827,326
+144,772
+21% +$15.1M 0.11% 189
2013
Q4
$70.5M Sell
682,554
-42,440
-6% -$4.16M 0.09% 236
2013
Q3
$67.7M Buy
724,994
+128,507
+22% +$11.8M 0.1% 206
2013
Q2
$50.3M Buy
+596,487
New +$47.1M 0.09% 261

Other funds holding HUM

Citadel Advisors's HUM Position: Q1 2026 in Review

Citadel Advisors increased its Humana (HUM) stake by 320% in Q1 2026, buying an estimated $22.1M and bringing the position to 141,650 shares worth $24.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Citadel Advisors first reported a position in HUM in Q2 2013 and has held it in 50 quarters since. The position peaked at $774M in Q3 2023. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Citadel Advisors held 141,650 shares of Humana worth $24.6M as of Q1 2026.
  • Citadel Advisors bought 107,899 Humana shares in Q1 2026, an estimated $22.1M.
  • Humana made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2083 holding.
  • Citadel Advisors first reported a position in Humana in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Humana position peaked at $774M in Q3 2023.
  • 780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.